Article

The prevalence of hepatic steatosis and metabolic associated fatty liver disease among breast cancer survivors

2021-03-18

Abstract excerpt

<title>Abstract</title> <p>Background and aimsAn international expert consensus statement was released on 2020 that non-alcoholic fatty liver disease (NAFLD) should be replaced by metabolic associated fatty liver disease (MAFLD) and hepatic steatosis (HS) is fundamental for the diagnosis of MAFLD in the new set of criteria. While female breast cancer has surpassed lung cancer as the most commonly diagnosed malign...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b6e43188-d28f-578f-b5d5-8f4b2fdae2f6
DOI: 10.21203/rs.3.rs-325344/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The prevalence of hepatic steatosis and metabolic associated fatty liver disease among breast cancer survivorsDOI 10.21203/rs.3.rs-325344/v1Read

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.Semantic proximity Read

Prevalence Of Fatty Liver Disease And Associated Factors Among Outpatients At Muhas Academic Medical Centre,tanzaniaSemantic proximity Read

Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional studySemantic proximity Read

Machine learning-based mortality prediction models for non-alcoholic fatty liver disease in the general United States populationSemantic proximity Read

Utility of Six Novel Anthropometric Indicators for Assessing Metabolic Dysfunction-Associated Steatotic Liver Disease in US Reproductive-Aged Women: An NHANES Cross-Sectional StudySemantic proximity Read

Risk Factors of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisSemantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

Relationship between the Incidence of Metabolic Syndrome and Breast CancerSemantic proximity Read

MAFLD: an optimal framework for understanding liver cancer phenotypes.Semantic proximity Read

Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease.Semantic proximity Read

Burden of Liver Cancer Attributable to Five Risk Factors by Specific Etiologies in 204 Countries and TerritoriesSemantic proximity Read